[HTML][HTML] RNA therapy: Are we using the right molecules?

AM Yu, C Jian, HY Allan, MJ Tu - Pharmacology & therapeutics, 2019 - Elsevier
Small-molecule and protein/antibody drugs mainly act on genome-derived proteins to exert
pharmacological effects. RNA based therapies hold the promise to expand the range of …

[HTML][HTML] Endpoints for clinical trials in ophthalmology

L Schmetterer, H Scholl, G Garhöfer… - Progress in Retinal and …, 2023 - Elsevier
With the identification of novel targets, the number of interventional clinical trials in
ophthalmology has increased. Visual acuity has for a long time been considered the gold …

Gene Editing for CEP290-Associated Retinal Degeneration

EA Pierce, TS Aleman, KT Jayasundera… - … England Journal of …, 2024 - Mass Medical Soc
Background CEP290-associated inherited retinal degeneration causes severe early-onset
vision loss due to pathogenic variants in CEP290. EDIT-101 is a clustered regularly …

[HTML][HTML] Effect of an intravitreal antisense oligonucleotide on vision in Leber congenital amaurosis due to a photoreceptor cilium defect

AV Cideciyan, SG Jacobson, AV Drack, AC Ho… - Nature medicine, 2019 - nature.com
Photoreceptor ciliopathies constitute the most common molecular mechanism of the
childhood blindness Leber congenital amaurosis. Ten patients with Leber congenital …

Splice-modulating oligonucleotide QR-110 restores CEP290 mRNA and function in human c. 2991+ 1655A> G LCA10 models

K Dulla, M Aguila, A Lane, K Jovanovic… - … Therapy-Nucleic Acids, 2018 - cell.com
Leber congenital amaurosis type 10 (LCA10) is a severe inherited retinal dystrophy
associated with mutations in CEP290. The deep intronic c. 2991+ 1655A> G mutation in …

[HTML][HTML] Primary cilia biogenesis and associated retinal ciliopathies

HY Chen, RA Kelley, T Li, A Swaroop - Seminars in cell & developmental …, 2021 - Elsevier
The primary cilium is a ubiquitous microtubule-based organelle that senses external
environment and modulates diverse signaling pathways in different cell types and tissues …

Leber congenital amaurosis/early-onset severe retinal dystrophy: current management and clinical trials

MD Varela, TAC de Guimaraes, M Georgiou… - British Journal of …, 2022 - bjo.bmj.com
Leber congenital amaurosis (LCA) is a severe congenital/early-onset retinal dystrophy.
Given its monogenic nature and the immunological and anatomical privileges of the eye …

[HTML][HTML] Full-field stimulus testing: role in the clinic and as an outcome measure in clinical trials of severe childhood retinal disease

AJ Roman, AV Cideciyan, V Wu, AV Garafalo… - Progress in Retinal and …, 2022 - Elsevier
Disease mechanisms have become better understood in previously incurable forms of early-
onset severe retinal dystrophy, such as Leber congenital amaurosis (LCA). This has led to …

[HTML][HTML] Durable vision improvement after a single treatment with antisense oligonucleotide sepofarsen: a case report

AV Cideciyan, SG Jacobson, AC Ho, AV Garafalo… - Nature medicine, 2021 - nature.com
Leber congenital amaurosis due to CEP290 ciliopathy is being explored by treatment with
the antisense oligonucleotide (AON) sepofarsen. One patient who was part of a larger cohort …

Leber congenital amaurosis due to cep290 mutations—Severe vision impairment with a high unmet medical need: A Review

BP Leroy, DG Birch, JL Duncan, BL Lam… - Retina, 2021 - journals.lww.com
Purpose: Leber congenital amaurosis due to CEP290 mutations (LCA10) is an inherited
retinal disease that often results in severe visual impairment or blindness in early childhood …